The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis
Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumul...
Saved in:
Published in | Journal of cardiovascular pharmacology and therapeutics Vol. 29; p. 10742484241248046 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Los Angeles, CA
SAGE Publications
01.01.2024
SAGE Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway. |
---|---|
AbstractList | Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway.Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway. Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway. |
Author | Zhang, Xin Zhang, Fengxia Liang, Pengpeng Feng, Yanan Liu, Hongshuai Yu, Wenfei Chen, Suwen Yin, Guoliang Meng, Decheng |
Author_xml | – sequence: 1 givenname: Xin surname: Zhang fullname: Zhang, Xin email: fxzhang0987@163.com – sequence: 2 givenname: Suwen surname: Chen fullname: Chen, Suwen – sequence: 3 givenname: Guoliang surname: Yin fullname: Yin, Guoliang – sequence: 4 givenname: Pengpeng surname: Liang fullname: Liang, Pengpeng – sequence: 5 givenname: Yanan surname: Feng fullname: Feng, Yanan – sequence: 6 givenname: Wenfei surname: Yu fullname: Yu, Wenfei – sequence: 7 givenname: Decheng surname: Meng fullname: Meng, Decheng – sequence: 8 givenname: Hongshuai surname: Liu fullname: Liu, Hongshuai – sequence: 9 givenname: Fengxia orcidid: 0000-0002-9574-8155 surname: Zhang fullname: Zhang, Fengxia email: fxzhang0987@163.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38656132$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtv3CAUhVGVqnm0P6CbimU3TsA8bC9HadJOGqlV464RhusJIw8kgBXl3xd3ki5SKQu46PKdAzr3GB344AGhj5ScUto0Z5Q0vOZtWbQUwuUbdEQ7TipOGD8o53JfLcAhOk5pS0hpi-4dOmStFJKy-gjd97eAf4UJcBjx1er72U2_6vGN23g9Ob_BP3W-fdCPWHuL1znhL-HBpxxB7_Daj9MM3izYpTY5xISdx7kY9gXIO_B5cV2VTgzJTMvu0nv0dtRTgg9P9QT9vrzoz79V1z--rs9X15XhvMuVacFKK3jXARuaUbSMUALCcDHYFriUtmmAFZbZlnSNBeBgzUCJNoxoMbATtN772qC36i66nY6PKmin_jZC3CgdsyvfUqNsTSepqaWhJSDQQktBgRpeM1Y3XfH6vPe6i-F-hpTVziUD06Q9hDkpVrIXtKWUFfTTEzoPO7D_Hn6OvADNHjAljhRhVMZlnV3wOWo3KUrUMlz133CLkr5QPpu_pjnda5LegNqGOZbBplcEfwBHcbD5 |
CitedBy_id | crossref_primary_10_3389_fimmu_2024_1437821 crossref_primary_10_3390_ph17111426 crossref_primary_10_1016_j_jds_2024_09_021 crossref_primary_10_1007_s12035_025_04834_4 crossref_primary_10_1016_j_obmed_2025_100585 crossref_primary_10_3390_cells14030153 |
Cites_doi | 10.1038/s41572-019-0106-z 10.1016/j.intimp.2021.108117 10.1186/1476-9255-8-34 10.1084/jem.20090545 10.1016/j.cell.2022.09.023 10.1042/bj20030407 10.1093/cvr/cvy007 10.1016/j.abb.2012.09.007 10.1007/978-981-15-4272-5_18 10.1038/s41569-019-0227-9 10.1126/science.8197455 10.7150/ijbs.46651 10.1016/bs.apcsb.2019.11.002 10.1016/j.tcm.2021.02.001 10.4049/jimmunol.1101228 10.1016/j.biopha.2021.112358 10.3390/ijms21020418 10.1126/scitranslmed.aax0481 10.1080/15384101.2022.2066295 10.1073/pnas.84.8.2396 10.1016/j.vph.2005.08.021 10.1016/j.cell.2022.04.004 10.1016/S0140-6736(21)00438-4 10.1161/CIRCULATIONAHA.120.052604 10.1111/jcmm.16003 10.3389/fimmu.2021.714943 10.1016/j.jacc.2005.09.068 10.1186/s13046-019-1428-0 10.1016/j.biopha.2022.112781 10.1038/s42255-019-0102-3 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H 10.1111/j.1600-065X.2008.00698.x 10.1016/j.bbrc.2006.04.010 10.1038/s41467-023-36614-w 10.1016/j.exger.2004.04.011 10.1016/j.intimp.2022.109095 10.1038/aps.2015.87 10.1111/j.0959-9673.2003.00363.x 10.1016/j.phymed.2022.154385 10.1093/eurheartj/ehab447 10.1016/S0002-9440(10)64820-1 10.1016/j.cca.2017.11.005 10.1371/journal.pone.0051608 10.1007/s13277-015-3534-8 10.1016/j.tips.2021.11.001 10.3892/ijmm.2013.1323 10.1101/cshperspect.a016295 10.3389/fimmu.2022.954706 10.1038/s41420-022-00906-9 10.1016/0092-8674(93)90508-N 10.1038/s41392-021-00507-5 10.1097/00024382-200202000-00001 10.1161/CIRCRESAHA.118.311362 10.1016/j.bbrc.2017.06.020 10.1089/ars.2013.5371 10.1161/01.CIR.0000148135.08582.97 10.3390/ijms20133328 10.1002/mc.2940080402 10.1016/j.semcancer.2013.05.008 10.1136/annrheumdis-2020-219012 10.1016/j.intimp.2020.106210 10.1080/01926230701320337 10.1038/sj.onc.1209281 10.1016/j.biopha.2022.113775 10.1101/cshperspect.a021873 10.18632/aging.103034 10.1161/ATVBAHA.108.173781 10.1074/jbc.M704267200 10.1161/CIRCRESAHA.121.319077 10.1093/eurheartj/ehy310 10.1111/jcmm.12923 10.1038/nature15514 10.1161/CIRCRESAHA.122.320877 10.1016/j.cardiores.2007.02.022 10.18632/aging.100934 10.1038/s41392-021-00791-1 10.1007/s40265-017-0701-9 10.1007/s10753-015-0135-z 10.1186/s40164-022-00283-0 10.1038/nature22393 10.1136/annrheumdis-2013-203756 10.1161/ATVBAHA.114.304144 10.3389/fimmu.2018.01135 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 |
Copyright_xml | – notice: The Author(s) 2024 |
DBID | AFRWT AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.1177/10742484241248046 |
DatabaseName | Sage Journals GOLD Open Access 2024 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ: Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: AFRWT name: Sage Journals GOLD Open Access 2024 url: http://journals.sagepub.com/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1940-4034 |
ExternalDocumentID | oai_doaj_org_article_f68c961c26c1459ea5a651e1c4233279 38656132 10_1177_10742484241248046 10.1177_10742484241248046 |
Genre | Journal Article Review |
GroupedDBID | --- -TM .2F .2G 01A 0R~ 18M 29K 31S 31Y 36B 4.4 53G 54M 5GY 5VS AABMB AACKU AADUE AAGGD AAJIQ AAJOX AAJPV AANSI AAPEO AAQDB AAQGT AAQXH AARDL AARIX AASGM AAWTL AAXOT AAYTG AAZBJ ABAWP ABCCA ABDWY ABEIX ABFWQ ABHKI ABJIS ABJNI ABKRH ABPGX ABQKF ABQXT ABRHV ABVFX ABVVC ABXGC ABYTW ACARO ACBMB ACDSZ ACDXX ACFMA ACFYK ACGBL ACGFS ACLHI ACOFE ACROE ACRPL ADBBV ADEBD ADEIA ADMPF ADNBR ADNMO ADOGD ADPDF ADSTG ADTBJ ADUKL ADYCS ADZZY AECVZ AENEX AEQLS AERKM AEUHG AEWDL AEXFG AEXNY AFCOW AFEET AFKBI AFKRG AFRWT AFUIA AFWMB AGNHF AGQPQ AHHFK AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI ALMA_UNASSIGNED_HOLDINGS ARTOV ASPBG AUTPY AUVAJ AVWKF AYAKG AZFZN B8M B8O B93 BDDNI BKSCU BSEHC CAG CBRKF CDWPY CFDXU COF CORYS CQQTX CS3 CUTAK D-I DC- DC. DC0 DD- DD0 DE- DOPDO DU5 D~Y EBD EBS EJD EMB EMOBN F5P FEDTE GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HVGLF HZ~ J8X K.F K.J LXL LXN MK0 N9A O9- OK1 OVD OVEED P.B Q1R Q7K Q7R Q7X Q82 ROL RWL S01 SAUOL SCDPB SCNPE SFB SFC SFN SGA SGP SGX SQCSI SV3 TAE TEORI ZONMY ZPPRI ZRKOI ZSSAH AAYXX ACHEB CITATION 31X AADTT AAMGE AATBZ ABHQH ACGZU ACSBE ACSIQ ACTQU ACUIR AEUIJ AEWHI AIOMO B8Z CGR CUY CVF DV7 ECM EIF M4V NPM SFK SFT SGV SPJ 7X8 |
ID | FETCH-LOGICAL-c449t-c8ed6d5499e3b7f583010e5c45bd8e466d77e3c443d8097dee4edcb10ac30a5b3 |
IEDL.DBID | AFRWT |
ISSN | 1074-2484 1940-4034 |
IngestDate | Wed Aug 27 01:19:51 EDT 2025 Fri Jul 11 16:10:05 EDT 2025 Wed Feb 19 01:58:52 EST 2025 Thu Apr 24 23:08:56 EDT 2025 Tue Jul 01 05:25:19 EDT 2025 Tue Jun 17 22:35:43 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Keywords | atherosclerosis apoptosis cytokines JAK/STAT inflammation |
Language | English |
License | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c449t-c8ed6d5499e3b7f583010e5c45bd8e466d77e3c443d8097dee4edcb10ac30a5b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-9574-8155 |
OpenAccessLink | https://journals.sagepub.com/doi/full/10.1177/10742484241248046?utm_source=summon&utm_medium=discovery-provider |
PMID | 38656132 |
PQID | 3046518113 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f68c961c26c1459ea5a651e1c4233279 proquest_miscellaneous_3046518113 pubmed_primary_38656132 crossref_citationtrail_10_1177_10742484241248046 crossref_primary_10_1177_10742484241248046 sage_journals_10_1177_10742484241248046 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-01-01 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Los Angeles, CA |
PublicationPlace_xml | – name: Los Angeles, CA – name: United States |
PublicationTitle | Journal of cardiovascular pharmacology and therapeutics |
PublicationTitleAlternate | J Cardiovasc Pharmacol Ther |
PublicationYear | 2024 |
Publisher | SAGE Publications SAGE Publishing |
Publisher_xml | – name: SAGE Publications – name: SAGE Publishing |
References | Darnell, Kerr, Stark 1994; 264 Jiang, Zhao, Mao, Wang, Zheng, You 2019; 38 Fietta, Costa, Delsante 2014; 107 Whitman, Ravisankar, Elam, Daugherty 2000; 157 Michalska, Blaszczyk, Wesoly, Bluyssen 2018; 9 Kubo, Yamaoka, Kondo 2014; 73 Gharavi, Alva, Mouillesseaux 2007; 282 Grothusen, Schuett, Hillmer 2012; 7 Cao, Jia, Yan, Chen, Xing, Shen 2019; 20 Yu, Zhang, Liu, Tang, Peng, Chen 2021; 6 Goumans, Ten Dijke 2018; 10 Tanaka, Narazaki, Kishimoto 2014; 6 Grebe, Hoss, Latz 2018; 122 Pistritto, Trisciuoglio, Ceci, Garufi, D'Orazi 2016; 8 Falk 2006; 47 Wang, Gao, Shi 2017; 547 2022; 21 Miao, Zang, Cui, Zhang 2020; 1207 Ridker, Libby, MacFadyen 2018; 39 Tipping, Hancock 1993; 142 Fu, Sun, Long 2022; 105 Schieffer, Selle, Hilfiker 2004; 110 Cai, Cai, Luo, Chen, Zhang 2015; 38 Zhang, Boisson-Dupuis, Chapgier 2008; 226 Basatemur, Jorgensen, Clarke, Bennett, Mallat 2019; 16 Guo, Zhou, Xie 2022; 155 Cagnina, Chabot, Davin 2022; 77 Elmore 2007; 35 Prabhu, Bhat, Siveen 2021; 144 Cooney 2002; 17 Libby, Buring, Badimon 2019; 5 Pietrocola, Izzo, Niso-Santano 2013; 23 Zhu, Jian, Zhong 2021; 12 Ortiz-Munoz, Martin-Ventura, Hernandez-Vargas 2009; 29 McLornan, Pope, Gotlib, Harrison 2021; 398 Heiser, Labi, Erlacher, Villunger 2004; 39 Li, Huang, Zhao, Yan, Lu 2020; 16 Grote, Luchtefeld, Schieffer 2005; 43 Borras, Mas-Bargues, Roman-Dominguez 2020; 21 Munjal, Khandia 2020; 120 Bakhshi, Wright, Graninger 1987; 84 Wang, Wang, Wang, Yun, Wang, Wang 2017; 490 Lu, Stump, Wallace 2011; 187 Shao, Han, Zeng, Su, Liu 2016; 37 Li, Liu, Chen 2006; 344 Baldini, Moriconi, Galimberti, Libby, De Caterina 2021; 42 Zhang, Huang, Li 2012; 528 Kim, Oh, Park 2021; 35 Taleb, Romain, Ramkhelawon 2009; 206 Xin, Xu, Deng 2020; 80 Liang, He, Chen 2013; 31 Ridker, Rane 2021; 128 Biros, Reznik, Moran 2022; 32 Banerjee, Biehl, Gadina, Hasni, Schwartz 2017; 77 Yao, Jin, Zheng 2022; 8 Xu, Ye 2022; 11 Hu, Li, Fu, Zhao, Wang 2021; 6 Kelley, Jeltema, Duan, He 2019; 20 Mackesy, Goalstone 2011; 8 Kim, Shin, Chung, Lee, Baek, Lee 2019; 8 Kamtchum-Tatuene, Saba, Heldner 2022; 131 Wei, Lan, Zheng 2023; 14 Spitz, Gavathiotis 2022; 43 Boise, Gonzalez-Garcia, Postema 1993; 74 Shi, Zhao, Wang 2015; 526 Stephanou, Latchman 2003; 84 Hu, Liu, Zhang 2022; 111 Morikawa, Derynck, Miyazono 2016; 8 Wang, Zhao, Wang, Wang, Liu, Zhang 2021; 100 Zhao, Ou, Wang, Yan, Chi 2017; 9 Barrett, Schlegel, Zhou 2019; 11 Huang, Li, Zhang 2020; 24 Tubaro, Guido, Sciarra, Mustilli, Carbone, D'Errico 2000; 15 Parzych, Klionsky 2014; 20 Liu, Zhang, Wang 2022; 13 Zhang, Alcaide, Liu 2011; 6 Georgakis, Malik, Li 2021; 143 Bian, Jing, Yang 2020; 12 Idriss, Naismith 2000; 50 Grainger 2007; 74 Li, Zhao, Shi 2015; 36 Gao, Liu, Yuan 2016; 20 Ogata, Chinen, Yoshida 2006; 25 Heinrich, Behrmann, Haan, Hermanns, Muller-Newen, Schaper 2003; 374 Chen, Qin, Li 2019; 1 Bjorkegren, Lusis 2022; 185 Xu, Lai, Hua 2019; 39 McDonnell 1993; 8 Grootaert, Moulis, Roth 2018; 114 Recio, Oguiza, Lazaro, Mallavia, Egido, Gomez-Guerrero 2014; 34 Xu, Li, Wang, Cao 2022; 148 Traves, Murray, Campigotto, Galien, Meng, Di Paolo 2021; 80 Philips, Wang, Cheon 2022; 185 Xu, Zheng, Hu, Wang 2018; 476 Ridker PM (bibr25-10742484241248046) 2018; 39 Ridker PM (bibr31-10742484241248046) 2021; 128 Jiang L (bibr75-10742484241248046) 2019; 38 Barrett TJ (bibr20-10742484241248046) 2019; 11 Kim CW (bibr47-10742484241248046) 2021; 35 Zhang SY (bibr34-10742484241248046) 2008; 226 Baldini C (bibr8-10742484241248046) 2021; 42 Yu P (bibr79-10742484241248046) 2021; 6 Banerjee S (bibr9-10742484241248046) 2017; 77 Liang X (bibr16-10742484241248046) 2013; 31 Whitman SC (bibr36-10742484241248046) 2000; 157 Michalska A (bibr38-10742484241248046) 2018; 9 Cao H (bibr69-10742484241248046) 2019; 20 Cooney RN (bibr14-10742484241248046) 2002; 17 Morikawa M (bibr52-10742484241248046) 2016; 8 Basatemur GL (bibr61-10742484241248046) 2019; 16 Tanaka T (bibr23-10742484241248046) 2014; 6 Kelley N (bibr85-10742484241248046) 2019; 20 Kubo S (bibr41-10742484241248046) 2014; 73 Munjal A (bibr24-10742484241248046) 2020; 120 Gao W (bibr46-10742484241248046) 2016; 20 Borras C (bibr64-10742484241248046) 2020; 21 Pietrocola F (bibr92-10742484241248046) 2013; 23 Spitz AZ (bibr72-10742484241248046) 2022; 43 Li HX (bibr6-10742484241248046) 2015; 36 Parzych KR (bibr88-10742484241248046) 2014; 20 McLornan DP (bibr94-10742484241248046) 2021; 398 Wei Y (bibr84-10742484241248046) 2023; 14 Huang W (bibr78-10742484241248046) 2020; 24 Falk E (bibr93-10742484241248046) 2006; 47 Traves PG (bibr32-10742484241248046) 2021; 80 Wang L (bibr51-10742484241248046) 2021; 100 Bjorkegren JLM (bibr1-10742484241248046) 2022; 185 Hu L (bibr49-10742484241248046) 2022; 111 Li D (bibr58-10742484241248046) 2006; 344 Yao F (bibr83-10742484241248046) 2022; 8 Cai B (bibr13-10742484241248046) 2015; 38 Fietta P (bibr21-10742484241248046) 2014; 107 Heinrich PC (bibr30-10742484241248046) 2003; 374 Chen PY (bibr54-10742484241248046) 2019; 1 Miao J (bibr89-10742484241248046) 2020; 1207 Kim TW (bibr50-10742484241248046) 2019; 8 Xu F (bibr76-10742484241248046) 2022; 148 Xu YJ (bibr80-10742484241248046) 2018; 476 McDonnell TJ (bibr66-10742484241248046) 1993; 8 Tubaro M (bibr48-10742484241248046) 2000; 15 Guo S (bibr56-10742484241248046) 2022; 155 Mackesy DZ (bibr44-10742484241248046) 2011; 8 Gharavi NM (bibr12-10742484241248046) 2007; 282 Zhu H (bibr87-10742484241248046) 2021; 12 Bakhshi A (bibr65-10742484241248046) 1987; 84 Philips RL (bibr7-10742484241248046) 2022; 185 Tipping PG (bibr45-10742484241248046) 1993; 142 Georgakis MK (bibr26-10742484241248046) 2021; 143 (bibr55-10742484241248046) 2022; 21 Stephanou A (bibr74-10742484241248046) 2003; 84 Li J (bibr22-10742484241248046) 2020; 16 Idriss HT (bibr43-10742484241248046) 2000; 50 Grothusen C (bibr17-10742484241248046) 2012; 7 Fu X (bibr11-10742484241248046) 2022; 105 Zhang J (bibr35-10742484241248046) 2011; 6 Liu W (bibr40-10742484241248046) 2022; 13 Wang Z (bibr33-10742484241248046) 2017; 490 Grote K (bibr5-10742484241248046) 2005; 43 Ogata H (bibr59-10742484241248046) 2006; 25 Cagnina A (bibr3-10742484241248046) 2022; 77 Goumans MJ (bibr53-10742484241248046) 2018; 10 Shi J (bibr81-10742484241248046) 2015; 526 Grebe A (bibr86-10742484241248046) 2018; 122 Libby P (bibr2-10742484241248046) 2019; 5 Zhao J (bibr71-10742484241248046) 2017; 9 Kamtchum-Tatuene J (bibr27-10742484241248046) 2022; 131 Xu Y (bibr67-10742484241248046) 2022; 11 Biros E (bibr37-10742484241248046) 2022; 32 Ortiz-Munoz G (bibr15-10742484241248046) 2009; 29 Prabhu KS (bibr77-10742484241248046) 2021; 144 Shao BZ (bibr90-10742484241248046) 2016; 37 Boise LH (bibr68-10742484241248046) 1993; 74 Hu X (bibr10-10742484241248046) 2021; 6 Darnell JE (bibr39-10742484241248046) 1994; 264 Recio C (bibr18-10742484241248046) 2014; 34 Grootaert MOJ (bibr91-10742484241248046) 2018; 114 Wang Y (bibr82-10742484241248046) 2017; 547 Pistritto G (bibr73-10742484241248046) 2016; 8 Zhang K (bibr28-10742484241248046) 2012; 528 Xu X (bibr60-10742484241248046) 2019; 39 Schieffer B (bibr29-10742484241248046) 2004; 110 Heiser D (bibr63-10742484241248046) 2004; 39 Bian W (bibr70-10742484241248046) 2020; 12 Taleb S (bibr19-10742484241248046) 2009; 206 Lu LD (bibr42-10742484241248046) 2011; 187 Xin P (bibr4-10742484241248046) 2020; 80 Grainger DJ (bibr57-10742484241248046) 2007; 74 Elmore S (bibr62-10742484241248046) 2007; 35 |
References_xml | – volume: 8 issue: 10 year: 2019 article-title: Anti-inflammatory mechanisms of Koreanaside A, a Lignan isolated from the flower of Forsythia koreana, against LPS-induced macrophage activation and DSS-induced colitis mice: the crucial role of AP-1, NF-kappaB, and JAK/STAT signaling publication-title: Cells – volume: 9 start-page: 1135 year: 2018 article-title: A positive feedback amplifier circuit that regulates interferon (IFN)-stimulated gene expression and controls type I and type II IFN responses publication-title: Front Immunol – volume: 547 start-page: 99 issue: 7661 year: 2017 end-page: 103 article-title: Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin publication-title: Nature – volume: 131 issue: 2 year: 2022 end-page: e33 article-title: Interleukin-6 predicts carotid plaque severity, vulnerability, and progression publication-title: Circ Res – volume: 74 start-page: 597 issue: 4 year: 1993 end-page: 608 article-title: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death publication-title: Cell – volume: 142 start-page: 1721 issue: 6 year: 1993 end-page: 1728 article-title: Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques publication-title: Am J Pathol – volume: 43 start-page: 357 issue: 5 year: 2005 end-page: 363 article-title: JANUS under stress–role of JAK/STAT signaling pathway in vascular diseases publication-title: Vascul Pharmacol – volume: 39 start-page: 1125 issue: 8 year: 2004 end-page: 1135 article-title: The Bcl-2 protein family and its role in the development of neoplastic disease publication-title: Exp Gerontol – volume: 77 start-page: 302 issue: 5-6 year: 2022 end-page: 309 article-title: Atherosclerosis, an inflammatory disease publication-title: Rev Med Liege – volume: 80 start-page: 106210 year: 2020 article-title: The role of JAK/STAT signaling pathway and its inhibitors in diseases publication-title: Int Immunopharmacol – volume: 17 start-page: 83 issue: 2 year: 2002 end-page: 90 article-title: Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway publication-title: Shock – volume: 5 start-page: 56 issue: 1 year: 2019 article-title: Atherosclerosis publication-title: Nat Rev Dis Primers – volume: 13 start-page: 954706 year: 2022 article-title: IFN-gamma, should not be ignored in SLE publication-title: Front Immunol – volume: 35 issue: 3 year: 2021 article-title: A strategy to prevent atherosclerosis via TNF receptor regulation publication-title: FASEB J – volume: 73 start-page: 2192 issue: 12 year: 2014 end-page: 2198 article-title: The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells publication-title: Ann Rheum Dis – volume: 120 start-page: 85 year: 2020 end-page: 122 article-title: Atherosclerosis: orchestrating cells and biomolecules involved in its activation and inhibition publication-title: Adv Protein Chem Struct Biol – volume: 50 start-page: 184 issue: 3 year: 2000 end-page: 195 article-title: TNF Alpha and the TNF receptor superfamily: structure-function relationship(s) publication-title: Microsc Res Tech – volume: 74 start-page: 213 issue: 2 year: 2007 end-page: 222 article-title: TGF-beta and atherosclerosis in man publication-title: Cardiovasc Res – volume: 24 start-page: 13949 issue: 23 year: 2020 end-page: 13960 article-title: IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer publication-title: J Cell Mol Med – volume: 42 start-page: 4389 issue: 42 year: 2021 end-page: 4400 article-title: The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms publication-title: Eur Heart J – volume: 1207 start-page: 237 year: 2020 end-page: 264 article-title: Autophagy, hyperlipidemia, and atherosclerosis publication-title: Adv Exp Med Biol – volume: 43 start-page: 206 issue: 3 year: 2022 end-page: 220 article-title: Physiological and pharmacological modulation of BAX publication-title: Trends Pharmacol Sci – volume: 8 issue: 5 year: 2016 article-title: TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology publication-title: Cold Spring Harb Perspect Biol – volume: 6 start-page: 128 issue: 1 year: 2021 article-title: Pyroptosis: mechanisms and diseases publication-title: Signal Transduct Target Ther – volume: 344 start-page: 701 issue: 3 year: 2006 end-page: 707 article-title: Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice publication-title: Biochem Biophys Res Commun – volume: 155 start-page: 113775 year: 2022 article-title: Resveratrol inhibiting TGF/ERK signaling pathway can improve atherosclerosis: backgrounds, mechanisms and effects publication-title: Biomed Pharmacother – volume: 8 start-page: 34 year: 2011 article-title: Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells publication-title: J Inflamm (Lond) – volume: 20 start-page: 3328 issue: 13 year: 2019 article-title: The NLRP3 inflammasome: an overview of mechanisms of activation and regulation publication-title: Int J Mol Sci – volume: 8 start-page: 209 issue: 4 year: 1993 end-page: 213 article-title: Cell division versus cell death: a functional model of multistep neoplasia publication-title: Mol Carcinog – volume: 77 start-page: 521 issue: 5 year: 2017 end-page: 546 article-title: JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects publication-title: Drugs – volume: 25 start-page: 2520 issue: 17 year: 2006 end-page: 2530 article-title: Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production publication-title: Oncogene – volume: 185 start-page: 1630 issue: 10 year: 2022 end-page: 1645 article-title: Atherosclerosis: recent developments publication-title: Cell – volume: 12 start-page: 714943 year: 2021 article-title: Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2/STAT3 pathway inhibition publication-title: Front Immunol – volume: 16 start-page: 727 issue: 12 year: 2019 end-page: 744 article-title: Vascular smooth muscle cells in atherosclerosis publication-title: Nat Rev Cardiol – volume: 11 start-page: 31 issue: 1 year: 2022 article-title: Progress in understanding the mechanisms of resistance to BCL-2 inhibitors publication-title: Exp Hematol Oncol – volume: 100 start-page: 108117 year: 2021 article-title: FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway publication-title: Int Immunopharmacol – volume: 20 issue: 23 year: 2019 article-title: Quercetin suppresses the progression of atherosclerosis by regulating MST1-mediated autophagy in ox-LDL-induced RAW264.7 macrophage foam cells publication-title: Int J Mol Sci – volume: 122 start-page: 1722 issue: 12 year: 2018 end-page: 1740 article-title: NLRP3 inflammasome and the IL-1 pathway in atherosclerosis publication-title: Circ Res – volume: 107 start-page: 13 issue: 1-2 year: 2014 end-page: 45 article-title: Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19 publication-title: Theor Biol Forum – volume: 490 start-page: 194 issue: 2 year: 2017 end-page: 201 article-title: Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice publication-title: Biochem Biophys Res Commun – volume: 144 start-page: 112358 year: 2021 article-title: Sanguinarine mediated apoptosis in non-small cell lung cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway publication-title: Biomed Pharmacother – volume: 11 issue: 517 year: 2019 article-title: Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis publication-title: Sci Transl Med – volume: 23 start-page: 310 issue: 5 year: 2013 end-page: 322 article-title: Regulation of autophagy by stress-responsive transcription factors publication-title: Semin Cancer Biol – volume: 110 start-page: 3493 issue: 22 year: 2004 end-page: 3500 article-title: Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis publication-title: Circulation – volume: 143 start-page: 1177 issue: 11 year: 2021 end-page: 1180 article-title: Genetically downregulated interleukin-6 signaling is associated with a favorable cardiometabolic profile: a phenome-wide association study publication-title: Circulation – volume: 157 start-page: 1819 issue: 6 year: 2000 end-page: 1824 article-title: Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice publication-title: Am J Pathol – volume: 80 start-page: 865 issue: 7 year: 2021 end-page: 875 article-title: JAK Selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib publication-title: Ann Rheum Dis – volume: 15 start-page: 108 issue: 1 year: 2000 end-page: 114 article-title: Atherosclerosis and simvastatin: new questions for the new millennium publication-title: Ann Ital Med Int – volume: 105 start-page: 154385 year: 2022 article-title: Glycosides from buyang huanwu decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway publication-title: Phytomedicine – volume: 29 start-page: 525 issue: 4 year: 2009 end-page: 531 article-title: Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis publication-title: Arterioscler Thromb Vasc Biol – volume: 6 issue: 10 year: 2014 article-title: IL-6 in inflammation, immunity, and disease publication-title: Cold Spring Harb Perspect Biol – volume: 8 start-page: 112 issue: 1 year: 2022 article-title: HDAC11 promotes both NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells publication-title: Cell Death Discov – volume: 398 start-page: 803 issue: 10302 year: 2021 end-page: 816 article-title: Current and future status of JAK inhibitors publication-title: Lancet – volume: 16 start-page: 2323 issue: 13 year: 2020 end-page: 2339 article-title: The role of interleukins in colorectal cancer publication-title: Int J Biol Sci – volume: 39 issue: 1 year: 2019 article-title: Apoptosis and apoptotic body: disease message and therapeutic target potentials publication-title: Biosci Rep – volume: 12 start-page: 6385 issue: 7 year: 2020 end-page: 6400 article-title: Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis publication-title: Aging (Albany NY) – volume: 32 start-page: 138 issue: 3 year: 2022 end-page: 142 article-title: Role of inflammatory cytokines in genesis and treatment of atherosclerosis publication-title: Trends Cardiovasc Med – volume: 526 start-page: 660 issue: 7575 year: 2015 end-page: 665 article-title: Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death publication-title: Nature – volume: 38 start-page: 1599 issue: 4 year: 2015 end-page: 1608 article-title: The specific roles of JAK/STAT signaling pathway in sepsis publication-title: Inflammation – volume: 6 start-page: 402 issue: 1 year: 2021 article-title: The JAK/STAT signaling pathway: from bench to clinic publication-title: Signal Transduct Target Ther – volume: 282 start-page: 31460 issue: 43 year: 2007 end-page: 8 article-title: Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo publication-title: J Biol Chem – volume: 206 start-page: 2067 issue: 10 year: 2009 end-page: 2077 article-title: Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis publication-title: J Exp Med – volume: 185 start-page: 3857 issue: 21 year: 2022 end-page: 3876 article-title: The JAK-STAT pathway at 30: much learned, much more to do publication-title: Cell – volume: 111 start-page: 109095 year: 2022 article-title: Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors publication-title: Int Immunopharmacol – volume: 9 start-page: 3433 issue: 7 year: 2017 end-page: 3442 article-title: MicroRNA-1907 enhances atherosclerosis-associated endothelial cell apoptosis by suppressing Bcl-2 publication-title: Am J Transl Res – volume: 7 issue: 12 year: 2012 article-title: Role of suppressor of cytokine signaling-1 in murine atherosclerosis publication-title: PLoS One – volume: 528 start-page: 127 issue: 2 year: 2012 end-page: 133 article-title: Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase alpha1 via a mitogen-activated protein kinase and c-Jun pathway publication-title: Arch Biochem Biophys – volume: 37 start-page: 150 issue: 2 year: 2016 end-page: 156 article-title: The roles of macrophage autophagy in atherosclerosis publication-title: Acta Pharmacol Sin – volume: 187 start-page: 3840 issue: 7 year: 2011 end-page: 3853 article-title: Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2 publication-title: J Immunol – volume: 8 start-page: 603 issue: 4 year: 2016 end-page: 619 article-title: Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies publication-title: Aging (Albany NY) – volume: 476 start-page: 28 year: 2018 end-page: 37 article-title: Pyroptosis and its relationship to atherosclerosis publication-title: Clin Chim Acta – volume: 39 start-page: 3499 issue: 38 year: 2018 end-page: 3507 article-title: Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS) publication-title: Eur Heart J – volume: 31 start-page: 1066 issue: 5 year: 2013 end-page: 1074 article-title: Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis publication-title: Int J Mol Med – volume: 36 start-page: 8671 issue: 11 year: 2015 end-page: 8678 article-title: Retinoic acid amide inhibits JAK/STAT pathway in lung cancer which leads to apoptosis publication-title: Tumour Biol – volume: 6 issue: 1 year: 2011 article-title: Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils publication-title: PLoS One – volume: 20 start-page: 460 issue: 3 year: 2014 end-page: 473 article-title: An overview of autophagy: morphology, mechanism, and regulation publication-title: Antioxid Redox Signal – volume: 35 start-page: 495 issue: 4 year: 2007 end-page: 516 article-title: Apoptosis: a review of programmed cell death publication-title: Toxicol Pathol – volume: 21 issue: 2 year: 2020 article-title: BCL-xL, a mitochondrial protein involved in successful aging: from C. elegans to human centenarians publication-title: Int J Mol Sci – volume: 226 start-page: 29 issue: 1 year: 2008 end-page: 40 article-title: Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense publication-title: Immunol Rev – volume: 34 start-page: 1953 issue: 9 year: 2014 end-page: 1960 article-title: Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice publication-title: Arterioscler Thromb Vasc Biol – volume: 20 start-page: 2318 issue: 12 year: 2016 end-page: 2327 article-title: Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-alpha mediated NF-kappaB pathway publication-title: J Cell Mol Med – volume: 84 start-page: 2396 issue: 8 year: 1987 end-page: 2400 article-title: Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners publication-title: Proc Natl Acad Sci U S A – volume: 128 start-page: 1728 issue: 11 year: 2021 end-page: 1746 article-title: Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease publication-title: Circ Res – volume: 38 start-page: 465 issue: 1 year: 2019 article-title: Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6 publication-title: J Exp Clin Cancer Res – volume: 264 start-page: 1415 issue: 5164 year: 1994 end-page: 1421 article-title: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins publication-title: Science – volume: 1 start-page: 912 issue: 9 year: 2019 end-page: 926 article-title: Endothelial TGF-beta signalling drives vascular inflammation and atherosclerosis publication-title: Nat Metab – volume: 114 start-page: 622 issue: 4 year: 2018 end-page: 634 article-title: Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis publication-title: Cardiovasc Res – volume: 84 start-page: 239 issue: 6 year: 2003 end-page: 244 article-title: STAT-1: a novel regulator of apoptosis publication-title: Int J Exp Pathol – volume: 148 start-page: 112781 year: 2022 article-title: Retraction notice to “Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a” [Biomed. Pharmacother. 112 (2019) 108592] publication-title: Biomed Pharmacother – volume: 10 issue: 2 year: 2018 article-title: TGF-beta signaling in control of cardiovascular function publication-title: Cold Spring Harb Perspect Biol – volume: 47 issue: 8 Suppl year: 2006 end-page: 12 article-title: Pathogenesis of atherosclerosis publication-title: J Am Coll Cardiol – volume: 14 start-page: 929 issue: 1 year: 2023 article-title: GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis publication-title: Nat Commun – volume: 374 start-page: 1 issue: Pt 1 year: 2003 end-page: 20 article-title: Principles of interleukin (IL)-6-type cytokine signalling and its regulation publication-title: Biochem J – volume: 21 start-page: 1437 issue: 13 year: 2022 article-title: Statement of retraction: 1,25(OH)2D3 improves blood lipid metabolism, liver function, and atherosclerosis by constraining the TGF-beta/Smad signaling pathway in rats with hyperlipidemia publication-title: Cell Cycle – volume: 5 start-page: 56 issue: 1 year: 2019 ident: bibr2-10742484241248046 publication-title: Nat Rev Dis Primers doi: 10.1038/s41572-019-0106-z – volume: 100 start-page: 108117 year: 2021 ident: bibr51-10742484241248046 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2021.108117 – volume: 8 start-page: 34 year: 2011 ident: bibr44-10742484241248046 publication-title: J Inflamm (Lond) doi: 10.1186/1476-9255-8-34 – volume: 206 start-page: 2067 issue: 10 year: 2009 ident: bibr19-10742484241248046 publication-title: J Exp Med doi: 10.1084/jem.20090545 – volume: 35 issue: 3 year: 2021 ident: bibr47-10742484241248046 publication-title: FASEB J – volume: 185 start-page: 3857 issue: 21 year: 2022 ident: bibr7-10742484241248046 publication-title: Cell doi: 10.1016/j.cell.2022.09.023 – volume: 374 start-page: 1 issue: 1 year: 2003 ident: bibr30-10742484241248046 publication-title: Biochem J doi: 10.1042/bj20030407 – volume: 114 start-page: 622 issue: 4 year: 2018 ident: bibr91-10742484241248046 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvy007 – volume: 528 start-page: 127 issue: 2 year: 2012 ident: bibr28-10742484241248046 publication-title: Arch Biochem Biophys doi: 10.1016/j.abb.2012.09.007 – volume: 1207 start-page: 237 year: 2020 ident: bibr89-10742484241248046 publication-title: Adv Exp Med Biol doi: 10.1007/978-981-15-4272-5_18 – volume: 16 start-page: 727 issue: 12 year: 2019 ident: bibr61-10742484241248046 publication-title: Nat Rev Cardiol doi: 10.1038/s41569-019-0227-9 – volume: 264 start-page: 1415 issue: 5164 year: 1994 ident: bibr39-10742484241248046 publication-title: Science doi: 10.1126/science.8197455 – volume: 16 start-page: 2323 issue: 13 year: 2020 ident: bibr22-10742484241248046 publication-title: Int J Biol Sci doi: 10.7150/ijbs.46651 – volume: 120 start-page: 85 year: 2020 ident: bibr24-10742484241248046 publication-title: Adv Protein Chem Struct Biol doi: 10.1016/bs.apcsb.2019.11.002 – volume: 32 start-page: 138 issue: 3 year: 2022 ident: bibr37-10742484241248046 publication-title: Trends Cardiovasc Med doi: 10.1016/j.tcm.2021.02.001 – volume: 187 start-page: 3840 issue: 7 year: 2011 ident: bibr42-10742484241248046 publication-title: J Immunol doi: 10.4049/jimmunol.1101228 – volume: 142 start-page: 1721 issue: 6 year: 1993 ident: bibr45-10742484241248046 publication-title: Am J Pathol – volume: 39 issue: 1 year: 2019 ident: bibr60-10742484241248046 publication-title: Biosci Rep – volume: 144 start-page: 112358 year: 2021 ident: bibr77-10742484241248046 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2021.112358 – volume: 21 issue: 2 year: 2020 ident: bibr64-10742484241248046 publication-title: Int J Mol Sci doi: 10.3390/ijms21020418 – volume: 11 issue: 517 year: 2019 ident: bibr20-10742484241248046 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aax0481 – volume: 21 start-page: 1437 issue: 13 year: 2022 ident: bibr55-10742484241248046 publication-title: Cell Cycle doi: 10.1080/15384101.2022.2066295 – volume: 84 start-page: 2396 issue: 8 year: 1987 ident: bibr65-10742484241248046 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.84.8.2396 – volume: 10 issue: 2 year: 2018 ident: bibr53-10742484241248046 publication-title: Cold Spring Harb Perspect Biol – volume: 43 start-page: 357 issue: 5 year: 2005 ident: bibr5-10742484241248046 publication-title: Vascul Pharmacol doi: 10.1016/j.vph.2005.08.021 – volume: 185 start-page: 1630 issue: 10 year: 2022 ident: bibr1-10742484241248046 publication-title: Cell doi: 10.1016/j.cell.2022.04.004 – volume: 398 start-page: 803 issue: 10302 year: 2021 ident: bibr94-10742484241248046 publication-title: Lancet doi: 10.1016/S0140-6736(21)00438-4 – volume: 143 start-page: 1177 issue: 11 year: 2021 ident: bibr26-10742484241248046 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.120.052604 – volume: 24 start-page: 13949 issue: 23 year: 2020 ident: bibr78-10742484241248046 publication-title: J Cell Mol Med doi: 10.1111/jcmm.16003 – volume: 12 start-page: 714943 year: 2021 ident: bibr87-10742484241248046 publication-title: Front Immunol doi: 10.3389/fimmu.2021.714943 – volume: 47 issue: 8 year: 2006 ident: bibr93-10742484241248046 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2005.09.068 – volume: 38 start-page: 465 issue: 1 year: 2019 ident: bibr75-10742484241248046 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1428-0 – volume: 148 start-page: 112781 year: 2022 ident: bibr76-10742484241248046 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2022.112781 – volume: 1 start-page: 912 issue: 9 year: 2019 ident: bibr54-10742484241248046 publication-title: Nat Metab doi: 10.1038/s42255-019-0102-3 – volume: 20 issue: 23 year: 2019 ident: bibr69-10742484241248046 publication-title: Int J Mol Sci – volume: 50 start-page: 184 issue: 3 year: 2000 ident: bibr43-10742484241248046 publication-title: Microsc Res Tech doi: 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H – volume: 226 start-page: 29 issue: 1 year: 2008 ident: bibr34-10742484241248046 publication-title: Immunol Rev doi: 10.1111/j.1600-065X.2008.00698.x – volume: 344 start-page: 701 issue: 3 year: 2006 ident: bibr58-10742484241248046 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2006.04.010 – volume: 14 start-page: 929 issue: 1 year: 2023 ident: bibr84-10742484241248046 publication-title: Nat Commun doi: 10.1038/s41467-023-36614-w – volume: 39 start-page: 1125 issue: 8 year: 2004 ident: bibr63-10742484241248046 publication-title: Exp Gerontol doi: 10.1016/j.exger.2004.04.011 – volume: 111 start-page: 109095 year: 2022 ident: bibr49-10742484241248046 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2022.109095 – volume: 37 start-page: 150 issue: 2 year: 2016 ident: bibr90-10742484241248046 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2015.87 – volume: 15 start-page: 108 issue: 1 year: 2000 ident: bibr48-10742484241248046 publication-title: Ann Ital Med Int – volume: 84 start-page: 239 issue: 6 year: 2003 ident: bibr74-10742484241248046 publication-title: Int J Exp Pathol doi: 10.1111/j.0959-9673.2003.00363.x – volume: 105 start-page: 154385 year: 2022 ident: bibr11-10742484241248046 publication-title: Phytomedicine doi: 10.1016/j.phymed.2022.154385 – volume: 42 start-page: 4389 issue: 42 year: 2021 ident: bibr8-10742484241248046 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehab447 – volume: 157 start-page: 1819 issue: 6 year: 2000 ident: bibr36-10742484241248046 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64820-1 – volume: 476 start-page: 28 year: 2018 ident: bibr80-10742484241248046 publication-title: Clin Chim Acta doi: 10.1016/j.cca.2017.11.005 – volume: 7 issue: 12 year: 2012 ident: bibr17-10742484241248046 publication-title: PLoS One doi: 10.1371/journal.pone.0051608 – volume: 36 start-page: 8671 issue: 11 year: 2015 ident: bibr6-10742484241248046 publication-title: Tumour Biol doi: 10.1007/s13277-015-3534-8 – volume: 43 start-page: 206 issue: 3 year: 2022 ident: bibr72-10742484241248046 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2021.11.001 – volume: 31 start-page: 1066 issue: 5 year: 2013 ident: bibr16-10742484241248046 publication-title: Int J Mol Med doi: 10.3892/ijmm.2013.1323 – volume: 6 issue: 10 year: 2014 ident: bibr23-10742484241248046 publication-title: Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a016295 – volume: 13 start-page: 954706 year: 2022 ident: bibr40-10742484241248046 publication-title: Front Immunol doi: 10.3389/fimmu.2022.954706 – volume: 8 start-page: 112 issue: 1 year: 2022 ident: bibr83-10742484241248046 publication-title: Cell Death Discov doi: 10.1038/s41420-022-00906-9 – volume: 107 start-page: 13 issue: 1 year: 2014 ident: bibr21-10742484241248046 publication-title: Theor Biol Forum – volume: 74 start-page: 597 issue: 4 year: 1993 ident: bibr68-10742484241248046 publication-title: Cell doi: 10.1016/0092-8674(93)90508-N – volume: 6 start-page: 128 issue: 1 year: 2021 ident: bibr79-10742484241248046 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00507-5 – volume: 17 start-page: 83 issue: 2 year: 2002 ident: bibr14-10742484241248046 publication-title: Shock doi: 10.1097/00024382-200202000-00001 – volume: 122 start-page: 1722 issue: 12 year: 2018 ident: bibr86-10742484241248046 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.118.311362 – volume: 490 start-page: 194 issue: 2 year: 2017 ident: bibr33-10742484241248046 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2017.06.020 – volume: 20 start-page: 460 issue: 3 year: 2014 ident: bibr88-10742484241248046 publication-title: Antioxid Redox Signal doi: 10.1089/ars.2013.5371 – volume: 110 start-page: 3493 issue: 22 year: 2004 ident: bibr29-10742484241248046 publication-title: Circulation doi: 10.1161/01.CIR.0000148135.08582.97 – volume: 20 start-page: 3328 issue: 13 year: 2019 ident: bibr85-10742484241248046 publication-title: Int J Mol Sci doi: 10.3390/ijms20133328 – volume: 77 start-page: 302 issue: 5 year: 2022 ident: bibr3-10742484241248046 publication-title: Rev Med Liege – volume: 8 start-page: 209 issue: 4 year: 1993 ident: bibr66-10742484241248046 publication-title: Mol Carcinog doi: 10.1002/mc.2940080402 – volume: 23 start-page: 310 issue: 5 year: 2013 ident: bibr92-10742484241248046 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2013.05.008 – volume: 80 start-page: 865 issue: 7 year: 2021 ident: bibr32-10742484241248046 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2020-219012 – volume: 6 issue: 1 year: 2011 ident: bibr35-10742484241248046 publication-title: PLoS One – volume: 80 start-page: 106210 year: 2020 ident: bibr4-10742484241248046 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2020.106210 – volume: 35 start-page: 495 issue: 4 year: 2007 ident: bibr62-10742484241248046 publication-title: Toxicol Pathol doi: 10.1080/01926230701320337 – volume: 25 start-page: 2520 issue: 17 year: 2006 ident: bibr59-10742484241248046 publication-title: Oncogene doi: 10.1038/sj.onc.1209281 – volume: 155 start-page: 113775 year: 2022 ident: bibr56-10742484241248046 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2022.113775 – volume: 8 issue: 5 year: 2016 ident: bibr52-10742484241248046 publication-title: Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a021873 – volume: 12 start-page: 6385 issue: 7 year: 2020 ident: bibr70-10742484241248046 publication-title: Aging (Albany NY) doi: 10.18632/aging.103034 – volume: 29 start-page: 525 issue: 4 year: 2009 ident: bibr15-10742484241248046 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.108.173781 – volume: 282 start-page: 31460 issue: 43 year: 2007 ident: bibr12-10742484241248046 publication-title: J Biol Chem doi: 10.1074/jbc.M704267200 – volume: 128 start-page: 1728 issue: 11 year: 2021 ident: bibr31-10742484241248046 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.121.319077 – volume: 39 start-page: 3499 issue: 38 year: 2018 ident: bibr25-10742484241248046 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy310 – volume: 20 start-page: 2318 issue: 12 year: 2016 ident: bibr46-10742484241248046 publication-title: J Cell Mol Med doi: 10.1111/jcmm.12923 – volume: 8 issue: 10 year: 2019 ident: bibr50-10742484241248046 publication-title: Cells – volume: 526 start-page: 660 issue: 7575 year: 2015 ident: bibr81-10742484241248046 publication-title: Nature doi: 10.1038/nature15514 – volume: 9 start-page: 3433 issue: 7 year: 2017 ident: bibr71-10742484241248046 publication-title: Am J Transl Res – volume: 131 issue: 2 year: 2022 ident: bibr27-10742484241248046 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.122.320877 – volume: 74 start-page: 213 issue: 2 year: 2007 ident: bibr57-10742484241248046 publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2007.02.022 – volume: 8 start-page: 603 issue: 4 year: 2016 ident: bibr73-10742484241248046 publication-title: Aging (Albany NY) doi: 10.18632/aging.100934 – volume: 6 start-page: 402 issue: 1 year: 2021 ident: bibr10-10742484241248046 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00791-1 – volume: 77 start-page: 521 issue: 5 year: 2017 ident: bibr9-10742484241248046 publication-title: Drugs doi: 10.1007/s40265-017-0701-9 – volume: 38 start-page: 1599 issue: 4 year: 2015 ident: bibr13-10742484241248046 publication-title: Inflammation doi: 10.1007/s10753-015-0135-z – volume: 11 start-page: 31 issue: 1 year: 2022 ident: bibr67-10742484241248046 publication-title: Exp Hematol Oncol doi: 10.1186/s40164-022-00283-0 – volume: 547 start-page: 99 issue: 7661 year: 2017 ident: bibr82-10742484241248046 publication-title: Nature doi: 10.1038/nature22393 – volume: 73 start-page: 2192 issue: 12 year: 2014 ident: bibr41-10742484241248046 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-203756 – volume: 34 start-page: 1953 issue: 9 year: 2014 ident: bibr18-10742484241248046 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.114.304144 – volume: 9 start-page: 1135 year: 2018 ident: bibr38-10742484241248046 publication-title: Front Immunol doi: 10.3389/fimmu.2018.01135 |
SSID | ssj0003459 |
Score | 2.3882954 |
SecondaryResourceType | review_article |
Snippet | Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor... |
SourceID | doaj proquest pubmed crossref sage |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 10742484241248046 |
SubjectTerms | Animals Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use Atherosclerosis - drug therapy Atherosclerosis - metabolism Humans Inflammation Mediators - metabolism Janus Kinase Inhibitors - pharmacology Janus Kinase Inhibitors - therapeutic use Janus Kinases - metabolism Signal Transduction STAT Transcription Factors - metabolism |
SummonAdditionalLinks | – databaseName: DOAJ: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9BLadKXk6aoUFIoMbFsS5aPm7ZLktKyNA7kZmRpFBZSu603lP33mbG1m5S-Lj3YB3tsD9LI80kz-oaxV94kUhvtY-FME-fQFLHxTlGQFwrtJfGJULbFJ3V8np9eyIs7pb4oJ2ykBx4b7tArbUslbKqsyGUJRholBQiLOCBLi2HrHvq81WQq_IMzFA0xTDFsLscZYK7xQHemE0K7d7zQQNb_O4T5U3bX4HCmD9mDgBT5ZNRwi92Ddpttfgyx8G22PxtZp5cHvLrdRNUf8H0-u-WjXj5i3_A2_9xdAe88P518ODyrJhU_m18SBm8v-QxB4A-z5KZ1_GTR83e04EwJ6F_4SShhQmLTsTIPn7ccQSOvVhnq9NYJwciuRz3xPO8fs_Pp--rtcRwqLcQ2z8tFbDU45WiqCFlTeKlx2CcgbS4bpyFXyhUFZCibOZ2UhQPIwdlGJMZmiZFN9oRttF0Lzxj3wkjIdGM8oPdPXGnRBRqTeuVNY2QZsWTV8rUNNORUDeOqFoF5_JfOitib9SNfRw6OvwkfUXeuBYk-e7iARlUHo6r_ZVQRe7kyhhqHG8VQTAvddV9TIFkiKhJZxJ6OVrL-FJVPRXSURuw1mU0d_gb9n5Xd-R_K7rL7KSKtcV3oOdtYfL-GPURKi-bFMChuABnxCXo priority: 102 providerName: Directory of Open Access Journals |
Title | The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis |
URI | https://journals.sagepub.com/doi/full/10.1177/10742484241248046 https://www.ncbi.nlm.nih.gov/pubmed/38656132 https://www.proquest.com/docview/3046518113 https://doaj.org/article/f68c961c26c1459ea5a651e1c4233279 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZpAqWX0qaPbB9BhZJCibt-SZZPxUm6JCktS-LQ3Iysx7KQtdvYS9l_3xlb3hCSlh7sgz22BmlG-jQzmiHkvZU-E1JYL9Cy9GJTJp60mqOT1yTCMswngtEW3_nxRXx6yS43SD2chXE92HzCsCrgqJusUbvRGj12TsYxRhGGsYALlicBW7zPy3ZR9ObuoaoGPkH_9HKBrm2FAZErbzje9oBshQlnoMlb2eTsR76evKO4q6_WhSliC84Rem-jt5ayLuP_fTD1VohYt2pNnpDHDm7SrJePp2TDVNvk4TfnUN8me9M-dfVqn-Y3J7GafbpHpzdJrVfPyC94Tc_qK0NrS0-zr-PzPMvp-XyGQL6a0Skgyd9yRWWl6Unb0CO0WmMU-4KeuDooSDbpy_vQeUUBedJ8CHPHv2aIResG-IT7vHlOLiZf8sNjz5Vr8FQcp62nhNFc437TRGVimYC5wzdMxazUwsSc6yQxEdBGWvhpoo2JjVZl4EsV-ZKV0QuyWdWV2SHUBpKZSJTSGoAQvk4VrKNShpZbWUqWjog_9HyhXC5zLKlxVQQuffmdwRqRj-tPfvaJPP5FfIDDuSbEHNzdg_p6VjiVLiwXKuWBCrkKQGqMZBIkygQKEGoUJsDku0EYCtBZdMTIytTLpkBvNANoFUQj8rKXknVTWIMVIFY4Ih9QbIpBIf7O7Kv_pnxNHoWAyXoL0huy2V4vzVvAVG256_Rgt7NJ_AGpiBhY |
linkProvider | SAGE Publications |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Za9wwEBbtBtq-lDa9tqcKJYUSp_ZakuVH91h2c7EkDs2bkXUsC4mdxhvK_vvO2FqH0LT0wX6wR_YgzWg-aUYzhHxwKuRSSRdERpUBs2USKGcEOnltIh3HfCIYbXEoJids95Sf-qhKPAvje7DZwbAq4KidrHvtbs-Jw2KOSbjAMklY3d0lGwyt1oBsZOOjH3k_D8esLZXWRhxiC-_TvPUjN6xSm7z_NsR5I9qrNUDjR-ShR44064b6Mbljq01y78D7xjfJ1qzLQr3apvn1oapmm27R2XV-6tUT8hNe06P6zNLa0d1s7_NxnuX0eDFHTF7N6QxA4S-1oqoydLps6DfcgMaA9HM69SVNkGzcVeqhi4oCiKT5OmIdv5ohrKwb4BPui-YpORl_z79OAl95IdCMpctAS2uEwaWjjcvEcQnTQGi5Zrw00jIhTJLYGGhjI8M0MdYya3QZhUrHoeJl_IwMqrqyLwh1keI2lqVyFtBAaFINJlGpkRNOlYqnQxKue77QPi05Vsc4KyKfifyPwRqST32Tiy4nx7-Iv-Bw9oSYTrt9UF_OC6-dhRNSpyLSI6EjkBqruBI8spEGsBmPEmDy_VoYClA_9KmoytZXTYGOZQ4oKYqH5HknJf2vsJwqoKXRkHxEsSnWsv13Zl_-N-U7cn-SH-wX-9PDvVfkwQigVrcx9JoMlpdX9g1ApWX51uvEbxEOBMw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegkyZeEIyvji8joSGhhebDdpzHwKjWDaZqy8TeIscfVaWRbEsn1P-eu8TtNDEQD8lDck5O9p3vZ9_5jpD3ToVcKumCyKgqYLZKA-WMQCevTaXjmE8Eoy2OxP4pOzjjZ37DDc_C-B5sP2FYFXDUTdao3RfGjbyPcYRBhDGTcIF1krDCu082GAPbOCAb-fj4R7GeixPWlUvrog6xhfdr3vmRW5apS-B_F-q8FfHVGaHxI_LQo0ea98P9mNyz9RbZ_O7941tkZ9pnol7u0uLmYFW7S3fo9CZH9fIJuYTX9Lg5t7Rx9CA_HJ0UeUFP5jPE5fWMTgEY_lJLqmpDJ4uW7uEmNAal_6QTX9YEycZ9tR46rykASVqsotbxqzlCy6YFPuE-b5-S0_HX4st-4KsvBJqxbBFoaY0wuHy0SZU6LmEqCC3XjFdGWiaESVObAG1iZJilxlpmja6iUOkkVLxKnpFB3dT2BaEuUtwmslLOAiIITabBLCoVO-FUpXg2JOGq50vtU5NjhYzzMvLZyP8YrCH5uG5y0efl-BfxZxzONSGm1O4eNFez0mto6YTUmYh0LHQEUmMVV4JHNtIAOJM4BSbfrYShBBVEv4qqbXPdluhc5oCUomRInvdSsv4VllQFxBQPyQcUm3Il339ndvu_Kd-SzeneuPw2OTp8SR7EgLb6vaFXZLC4uravAS0tqjdeJX4DCsAF3A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+JAK%2FSTAT+Signaling+Pathway+and+Its+Downstream+Influencing+Factors+in+the+Treatment+of+Atherosclerosis&rft.jtitle=Journal+of+cardiovascular+pharmacology+and+therapeutics&rft.au=Zhang%2C+Xin&rft.au=Chen%2C+Suwen&rft.au=Yin%2C+Guoliang&rft.au=Liang%2C+Pengpeng&rft.date=2024-01-01&rft.pub=SAGE+Publications&rft.issn=1074-2484&rft.eissn=1940-4034&rft.volume=29&rft_id=info:doi/10.1177%2F10742484241248046&rft.externalDocID=10.1177_10742484241248046 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1074-2484&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1074-2484&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1074-2484&client=summon |